Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain-Reference-Cited by-同舟云学术

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain

Published:2017-11-13 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Singh Manisha,Vianden Christina,Cantwell Mark J.,Dai Zhimin,Xiao Zhilan,Sharma Meenu,Khong Hiep^ORCID,Jaiswal Ashvin R.,Faak Faisal,Hailemichael Yared,Janssen L. M. E.,Bharadwaj Uddalak,Curran Michael A.,Diab Adi,Bassett Roland L.,Tweardy David J.,Hwu Patrick,Overwijk Willem W.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-01572-7.pdf

Reference34 articles.

1. Fonkem, E. et al. Melanoma brain metastasis: overview of current management and emerging targeted therapies. Expert. Rev. Neurother. 12, 1207–1215 (2012).

2. Postow, M. A. et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N. Engl. J. Med. 372, 2006–2017 (2015).

3. Rosenberg, S. A., Yang, J. C. & Restifo, N. P. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10, 909–915 (2004).

4. Marabelle, A. et al. Depleting tumor‐specific Tregs at a single site eradicates disseminated tumors. J. Clin. Invest. 123, 2447–2463 (2013).

5. Zamarin, D. et al. Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy. Sci. Transl. Med. 6, 226ra32 (2014).

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cells engineered to release interferon β and scFv-PD1 target glioblastoma and alter the tumor microenvironment;Cytotherapy;2024-05

2. Identification of Molecular Subtypes Based on Tertiary Lymphoid Structure in Skin Cutaneous Melanoma;J BIOL REG HOMEOS AG;2024

3. Construction and Identification of an NLR-Associated Prognostic Signature Revealing the Heterogeneous Immune Response in Skin Cutaneous Melanoma;Clinical, Cosmetic and Investigational Dermatology;2023-06

4. Adrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunity;Frontiers in Immunology;2023-03-15

5. Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity;Cancer Immunology Research;2023-03-08